SCHEMBL21687698

SCHEMBL21687698

N#Cc1ccc2c(c1)c1ccccc1n2-c1cccc(-c2cccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3)c2C#N)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.33
CYP1A2 P05177 5/20 0.33
CYP3A4 P08684 4/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CYP2C19 P33261 3/20 0.33
CLK4 Q9HAZ1 3/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CNR2 P34972 1/20 0.33
TDP2 O95551 5/20 0.33
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
RARG P13631 1/20 0.32
LMNA P02545 4/20 0.31
CYP2D6 P10635 3/20 0.31
HSD17B10 Q99714 3/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688006 0.97 TDP2 (0.34) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21687465 0.93 KDM4E (0.33) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21687989 0.93 KDM4E (0.35) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21687455 0.93 KDM4E (0.39) ALDH1A1MEN1KMT2AMAPK1KDM4E
SCHEMBL21688250 0.91 CYP1A2 (0.33) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21687529 0.91 METAP2 (0.33) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21688018 0.91 KDM4E (0.34) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21687709 0.91 CNR2 (0.35) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21688203 0.90 CYP1A2 (0.33) ALDH1A1CYP1A2CYP3A4MEN1KMT2A
SCHEMBL21687702 0.90 TDP2 (0.35) ALDH1A1CYP1A2CYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885CYP1A2 1346/4885CYP3A4 1290/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885CYP1A2 1346/4885CYP3A4 1290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.